Swine flu vaccine

The single-dose vaccine developed by Bharat Biotech's scientists at the Genome Valley facility in Hyderabad was launched on Monday, under the brand name HNVAC to help the country fight the spread of the disease.

Swine flu is back again and so is the panic linked with the virus. Emergence of fresh cases on a daily basis is a clear indication that the strain is ramping up very quickly once again.

Fifteen more people tested positive for the influenza in Mumbai on Wednesday taking the total number, affected by the disease, to 100 in the month of June.

The health authorities have assured the public that despite the surging number of infections, there was no need for panic as the situation was under control.

Serum Institute of India (SII) has received the green signal from the Drug Controller General of India (DCGI) to market the country’s first intra-nasal indigenous H1N1 flu vaccine.

The vaccine Nasovac, which is going to be launched in the domestic and the foreign market, is expected to hit the shelves for commercial use within the next 10 days.

Following extensive research and successful clinical trials, Cyrus Poonawalla, chief managing director of the SII, is already administering the vaccine to his staff, friends, children, and doctors.